CompoAtlas

ASHWAGANDHA SHODEN® GELULES

Food supplement declared in France, declaration No 2024-6-959, decision dated 18 June 2024

ASHWAGANDHA SHODEN® GELULES (NUTRIMUSCLE) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Withania somnifera 215 mg per day, Inuline. None of the rules we check flags an issue with its declared composition.

Brand
NUTRIMUSCLE
Food business operator placing the product on the market
SUPPLEMENTS DISTRIBUTION SRL
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
1 gélule
Directions for use
Prendre 1 gélule par jour au cours d’un repas.
Intended populations
People over 60, Men, Women
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Taking thyroid medication
Objectives stated by the manufacturer (these are not authorised claims)
Sport
Flavourings
NATURE

Declaration 242376, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Withania somnifera (L.) DunalPlante entièreExtrait sec aqueux215 mg

Other active ingredients

NamePer day
Inulinenot declared

Other ingredients

Gélule végétale

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Déconseillé aux enfants et aux adolescents. Les femmes enceintes et allaitantes, les personnes atteintes d’hyperthyroïdie ou d’hémochromatose sont invitées à prendre l’attache d’un professionnel de santé avant toute complémentation.Ne se substitue pas à une alimentation variée et équilibrée et à un mode de vie sain. Ne pas dépasser la portion journalière recommandée. À conserver au sec, à l’abri de la chaleur et de la lumière. Garder hors de portée des jeunes enfants. Ce produit a été développé et fabriqué conformément aux exigences de la norme NF EN 17444 à la date de production du lot. Produit fabriqué dans un atelier utilisant des allergènes (lait, œufs, céréales, soja, poisson, mollusques et crustacés).

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Withania somnifera (L.) Dunal
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    Sources cited by Health Canada (3)
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    Sources cited by Health Canada (3)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
    • Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : NUTRIMUSCLE

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “ASHWAGANDHA SHODEN® GELULES (NUTRIMUSCLE): composition and regulation”, https://compoatlas.com/en/supplements/products/242376-ashwagandha-shoden-gelules, updated 15 November 2026.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line